HealthDay - WEDNESDAY, Nov. 9 (HealthDay News) -- A new study suggests that the Cervarix cervical cancer vaccine may provide "excellent" protection against a precancerous lesion that is often a forerunner to invasive cervical cancer.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.